AlphaFold predicted structure
CYB5R3 · P00387

Mean pLDDT
93.9/ 100
Very high
301 residues
Confidence breakdown
- Very high(≥ 90)89%
- Confident(70–90)4%
- Low(50–70)4%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytochrome b5 reductase 3
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalRecessive hereditary methemoglobinemia type 1
Recessive hereditary methemoglobinemia type 2
methemoglobinemia due to deficiency of methemoglobin reductase
hereditary methemoglobinemia
central core myopathy
methemoglobinemia
Caffey disease
type 2 diabetes mellitus
hyperaldosteronism
musculoskeletal system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH-cytochrome b5 reductase 3
Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor
CYB5R3 · P00387

Mean pLDDT
93.9/ 100
Very high
301 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0